QuantuMDx announces approval of its Rapid Q-POCTM SARS-CoV-2 assay in the UK under CTDA legislation

2 years ago

QuantuMDx announces approval of its Rapid Q-POCTMSARS-CoV-2 assay in the UK under CTDA legislation NEWCASTLE UPON TYNE, UK, 22 February…

Nuvectis Announces Positive Data for NXP900 in Triple Negative Breast Cancer Preclinical Models with an Integrin-Linked Kinase (ILK) Loss

2 years ago

Data Published in Cancer Research, a journal of the American Association for Cancer Research Publication highlights potent activity of NXP900,…

World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I

2 years ago

In the Phase I clinical trial, participants were administered SPL026 and underwent a 20-minute psychedelic experience Phase I full dataset…

Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Developments on March 1, 2022

2 years ago

CAMBRIDGE, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare…

Teladoc Health Releases Annual Corporate Social Responsibility Report

2 years ago

Report Underscores Company’s Expanding Commitment to Being the ”Great Equalizer” in HealthcarePURCHASE, NY, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Teladoc…

Acer Therapeutics Announces Appointment of Adrian Quartel, M.D., FFPM, as Chief Medical Officer

2 years ago

Industry veteran with over 20 years of drug development experience to oversee advancement of Acer’s product pipeline Adrian Quartel, MD,…

Albireo to Report Q4 and Year-End 2021 Financial Results on March 1

2 years ago

— Conference call and webcast to be held at 10:00 a.m. ET —BOSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Albireo…

Pennsylvania-Based Health System Signs New Contract for Streamline Health® eValuator™

2 years ago

Regional Provider Chooses Automated Coding Analysis for Inpatient and Outpatient Care to Improve Revenue Performance Atlanta, GA, Feb. 22, 2022…

Chinook Therapeutics Announces Upcoming Presentations at 4th Annual Chronic Kidney Disease Drug Development Summit

2 years ago

SEATTLE, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development…

Akoya to Report Fourth Quarter and Full Year 2021 Financial Results on March 14th, 2022 and Present at the Cowen Annual Health Care Conference on March 8th, 2022

2 years ago

MARLBOROUGH, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced…